Skip to main content
Log in

17dd-yellow-fever-vaccine/methotrexate/prednisolone

Various toxicities, lack of efficacy and rebound effect in the form of worsening of diffuse retinal vasculitis: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Pereima RR, et al. Ocular Adverse Events following Yellow Fever Vaccination: A Case Series. Ocular Immunology and Inflammation 30: 1425-1429, No. 6, Jan 2022. Available from: URL: http://www.tandfonline.com/loi/ioii20

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

17dd-yellow-fever-vaccine/methotrexate/prednisolone. Reactions Weekly 1943, 14 (2023). https://doi.org/10.1007/s40278-023-32899-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32899-8

Navigation